Prostate specific antigen (PSA) is the most successful and widely employed cancer serum
marker in use today. There is growing evidence that the introduction of wide PSA screening …

Serum prostate-specific antigen (PSA) determination in conjunction with digital rectal
examination (DRE) is recommended by the majority of clinical guidelines for early detection …

BACKGROUND The purpose of the current study was to evaluate the effectiveness of a
prostate carcinoma screening program in which serum prostate‐specific antigen (PSA) …

Screening serum levels of prostate‐specific antigen (PSA) is now a major strategy for early
detection of prostate cancer (PC). Quantification of the lead time thus obtained is important …

BACKGROUND When age-referenced PSA levels as recommended by Oesterling et al. 1
were used as a biopsy criterion, only 25% of the cancers detected in a population based …

Recent studies have reported enhanced prostate cancer detection in Caucasians with
serum human glandular kallikrein 2 (hK2) in combination with total-(tPSA) and free-prostate …

An estimated 220,900 new cases of prostate cancer were diagnosed in the United States in
2003, and 28,900 men died of the disease during that year [1]. A global effort to decrease …

In 1970, Ablin et al [1, 2] reported on the existence of tissue-specific antigens in the normal
and pathologic prostate gland. In 1979, Wang et al [3] identified prostatic antigen, later …

Surveillance data represent a vital resource for understanding the impact of cancer control
interventions on the population cancer burden. However, population cancer trends are a …

PURPOSE:: Prostate cancer is the most common cancer in men and the second most
common cause of cancer death in men, and yet controversy continues to surround the …